Rare Disease Biotech Achieves Key Milestone with Promising Therapy for FPL – Patient Worthy

Rare Disease Biotech Achieves Key Milestone with Promising Therapy for FPL – Patient Worthy

A recent article from Pharmaceutical Manufacturer highlights a significant achievement in the rare disease sector, as Rare Disease Biotech announced reaching a major milestone in the development of its new therapy for familial partial lipodystrophy (FPL). This milestone marks an important step forward for patients living with this ultra-rare and often debilitating condition, which is […]